Batavia Biosciences significantly contributes to ease human suffering from infectious diseases and cancer by leveraging innovative technologies and in-depth know-how at all stages of the development trajectory. From the transition into early clinical studies to navigating late-stage clinical development and entering commercial manufacturing, the company accelerates processes with higher speed, reduced costs, and increased success rates. Operating state-of-the-art development and manufacturing facilities in Europe and the US, Batavia Biosciences is a science-based Contract Development and Manufacturing Organisation (CDMO) offering personalised services that fully support all stages of biopharmaceutical development, from cloning to GMP manufacture and release of clinical material for phase I/II studies.

Services include:
- Biologics
- Process Development
- Bioprocessing
- Cell Culture Media Development
- Chemistry (CMC)
- Manufacturing
- Contract Development and Manufacturing (CDMO)
- Mammalian Cell Culture
- Clinical Trial Materials
- Proteins
- Vaccines
- Process R&D
- Purification
- Quality QA/QC
- Cell and Gene Therapy
- Regulatory Services
- Protein and Peptide

Batavia Biosciences remains committed to advancing therapeutic solutions for critical health challenges, ensuring their clients receive comprehensive and expert support throughout the biopharmaceutical manufacturing process. For more information, please visit bataviabiosciences.com.